If the patient has a previous or existing care plan, when was it prepared and what were the outcomes? Other notes or comments relevant to the patient’s care planning: Mrs Mills recently developed a Dermatophyte superficial mycosis that has been resistant to topical treatments.

If the patient has a previous or existing care plan, when was it prepared and what were the outcomes?Other notes or comments relevant to the patient’s care planning:Mrs Mills recently developed a Dermatophyte superficial mycosis that has been resistant to topical treatments.
Order Description
PATIENT MEDICAL HISTORY FOR THIS ASSIGNMENT
RuckersvilleMedical ClinicDr Vern Geyer Dr Peter Whistock Dr Catherine ClarkM.B.B.S. FRACGP M.B.B.S. GradDipAppSci M.B.B.S.PN1111111J PN222222PK PN3333333L
Chronic Disease ManagementGP Management Plan & Team Care Arrangements MBS Item No. 721 & 723
Patients Name: Sophie Mills Date of Birth: 17/03/1950Contact Details: 49 Wattle Lane Medicare No.: 2121 31314 1/1Thurgoona NSW 2640Private Health Insurance Details:Details of Usual GP: Details of Patient’s Carer (If applicable):Dr Catherine Clark
If the patient has a previous or existing care plan, when was it prepared and what were the outcomes?Other notes or comments relevant to the patient’s care planning:Mrs Mills recently developed a Dermatophyte superficial mycosis that has been resistant to topical treatments.
HISTORY LISTActive:Date Condition14/03/2015 1. Dermatophyte mycosis18/08/2012 2. Rheumatoid arthritis11/12/2010 3. Gastric ulcers – Mild25/04/2009 4. Superficial thrombi lower limbs4/11/2008 5. Type 2 Diabetes Mellitus
Inactive:Date Condition
MEDICATIONSDrug NameScript StrengthDosageReasonLast
Astrix(Aspirin) 100 mg1 dailyIt’s mainly used for condition 4BUT it Astrix can also effect Condition 5 05/03/2015
Magicul(Cimetidine)400mg1 dailyCondition 316/01/2015
Diabex XR(Metformin)500mg1 dailyCondition 505/03/2015
Dexamethasonetablet(Dexamethasone)4 mg
2 dailyCondition 212/02/2015
Lozanoc® capsulesdaily(Itraconazole)100 mg
once
Condition 123/03/2015
ALLERGIES: No known allergiesFAMILY HISTORY: SOCIAL HISTORY:Nil Lives with husband. Has (x3) three adult children. No dependents.
This assignment is divided into part A and B.• Part A: is only focusing on Astrix (Aspirin) AND “Diabex XR (Metformin)• Part B: is only focusing on Astrix (Aspirin) AND Type 2 Diabetes MellitusPart A: A Drug-drug interaction (Max 2 pages)
A. Introduction: brief introductory statements about the drug-drug interaction and the two drug s you choose which are Astrix (Aspirin) AND Diabex XR (Metformin). (word limit 50)
B. Describe in a clear, detailed, succinct and logical manner the known interaction between the prescribed drugs “Astrix (Aspirin)” AND “Diabex XR (Metformin)”. Throughout the description make sure you include an accurate and clear explanation of how the interaction occurs. Include the following as you describe he drug-drug interaction (This part worth a lot of marks, it should have a lot of explanation):i. Paragraph 1: Astrix (Aspirin) normal pharmacodynamics• Firstly describe the normal pharmacodynamics? The main effect is treating superficial thrombi lower limbs but it can also lower the blood glucose level? YOU SHOULD MENTIONE OTHER EFFECTS OF THE DRUG to show that you understand the effects of the drug• Mechanism of action – describe the mechanism for ‘wanted and unwanted’ effects of the individual drugs? Without the drug-drug interaction; then? With the drug-drug interaction – the point you present here should be basis for elaborated in the section forii. Paragraph 2: Astrix (Aspirin) normal pharmacokinetics• Absorption• Distribution• Metabolism, and/or• Excretioniii. Paragraph 3: Diabex XR (Metformin) normal pharmacodynamics• Firstly describe the normal pharmacodynamics? The main effect is lower blood glucose level? YOU SHOULD MENTIONE OTHER EFFECTS OF THE DRUG to show that you understand the effects of the drug• Mechanism of action – describe the mechanism for ‘wanted and unwanted’ effects of the individual drugs? Without the drug-drug interaction; then? With the drug-drug interaction – the point you present here should be basis for elaborated in the section for 3rd CAiv. Paragraph 4: Diabex XR (Metformin) normal pharmacokinetics• Absorption• Distribution• Metabolism, and/or• Excretionv. Paragraph 5: explain the drug-drug interaction between Astrix (Aspirin)” AND “Diabex XR (Metformin). (How do they interact?) (Is the Astrix (Aspirin) pharmacokinetics going to affect the Diabex XR (Metformin) normal pharmacodynamics? Or vise versa) or (Is the Astrix (Aspirin) pharmacodynamics going to affect the Diabex XR (Metformin) pharmacokinetics? or vise versa )• Additionally, the description comprehensively describes how the interaction causes these effects, including all of the most pertinent details demonstrating an in-depth understanding of the drug-drug interaction.• A clear, well written, and logically organised description of what the drug-drug interaction affects• From the drug-drug interaction affects description, explain if it makes it clear whether or not the interaction is affecting pharmacodynamics and/or pharmacokinetics of one or both drugs and whether the interaction is antagonistic or agonistic• Don’t mention the word antagonistic or agonistic BUT show in your explanation that it is antagonistic or agonistic.

 
. .

The post If the patient has a previous or existing care plan, when was it prepared and what were the outcomes? Other notes or comments relevant to the patient’s care planning: Mrs Mills recently developed a Dermatophyte superficial mycosis that has been resistant to topical treatments. appeared first on cleanessays.com.